FDA Clears AI Tool for Pulmonary Hypertension Detection via Standard ECGs
The U.S. Food and Drug Administration has granted clearance to an artificial intelligence software designed to identify signs of untreated pulmonary hypertension using signals from standard 12-lead ECGs—a diagnostic test commonly available in clinical settings.
Pulmonary hypertension is a condition characterized by high blood pressure in the arteries